FDA Meeting on Patient Medication Information for Prescription Drugs
This post was written by Paul Sheives.
FDA announced a two-day public hearing to be held on September 27-28, 2010 to seek public input on a new framework for the development and distribution of patient medication information (PMI) to be provided to patients with prescription drug products. FDA is considering the use of a single, standardized document with consistent format and content. FDA seeks input on processes and procedures for standardizing PMI using a quality system approach for monitoring the development and distribution of PMI. Registration for the meeting closes September 13, 2010. FDA is accepting written comments on the issue until October 29, 2010.
